Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 648 results for "zydus cadila"

Zydus Wellness steps on gas: plans Everyuth re-launch, eyes bu...

The Rs 429-crore personal care arm of Ahmedabad-based pharmaceutical giant Cadila Healthcare, Zydus Wellness Ltd, which has been clocking a 3-4 per cent compounded growth rate in revenues for the past few years, has drawn up plans to propel the ... Smart Investor, 1 day ago
Zydus Cadila Q4 net rises 11% Business Standard India, 1 month ago

17 images for zydus cadila

Business Standard India, 1 week ago
VC Circle, 1 week ago
Pharma Letter, 1 week ago
Money Control, 3 weeks ago
India Infoline, 1 week ago
Business Standard India, 1 month ago
People Matters, 2 weeks ago
India Infoline, 1 week ago
Moneycontrol.com, 1 month ago
Financial Express, 1 month ago
VC Circle

Indian firm Zydus Cadila purchases two ANDAs from Teva

Indian pharmaceutical company Zydus Cadila has acquired two abbreviated new drug applications (ANDAs) from Israeli-American pharmaceutical company Teva. The two ANDAs are being sold out by Teva as a pre-condition to its acquisition of ...
 Pharmaceutical Technology1 week ago Cadila to acquire two drug forms from Teva to strengthen its US portfolio  Domain-B1 week ago Zydus Cadila acquires two drugs from Teva to strengthen US portfolio  VC Circle1 week ago Zydus acquires two new drug applications from Teva  Business Line1 week ago
[x]  
Business Standard India

Zydus Cadila partners with Eczacibasi to tap Turkish biosimilar market

As per the deal, Zydus will market biosimilars, which are currently unavailable in Turkey especially for the treatment of cancer BS B2B Bureau | Ahmedabad June 16, 2016 Last Updated at 15:04 IST The Ahmedabad-based Zydus Cadila yesterday signed a ...
 Business Standard India1 week ago Zydus Cadila inks strategic collaboration to market biosimilars in Turkey  Pharma Letter1 week ago India's Zydus Cadila and Eczacibasi to market biotech products in Turkey  CPhI.cn1 week ago Zydus Cadila collaborates with Eczacibasi Ilac Pazarlama Aims to increase reach in Turkish market via biosimilars & new products  EHealth Magazine1 week ago
[x]  
India Infoline

Zydus to sell biosimilars in Turkey

Healthcare provider Zydus Cadila, on Wednesday, announced the signing of a collaboration agreement with Turkeys Eczacibasi Ilac Pazarlama, A.S., to market biotech products in the Turkish market. The agreement involves import of biosimilars which are currently ...
 Business Line1 week ago Zydus teams up with Eczacibasi Ilac to market biosimilars in Turkey  Business Line1 week ago
India Infoline

Zydus Cadila inks pact with Turkish Healthcare for biosimilars

*Password should have 8 to 12 Alphanumeric Characters with one Special Character. Confirm Password I want to create a User ID and have read the terms and conditions for the same Register Now Connect with We encourage visitors to register on IIFL. Registering ...
 India Infoline1 week ago Zydus group inks pact with Eczacibasi to market biotech products  Economic Times1 week ago Zydus group, Eczacibasi ink pact to market biotech products  Money Control1 week ago Zydus Cadila, Eczacibasi ink pact to market biotech products  NetIndia123.com1 week ago
[x]  

Zydus Cadila, Eczacibasi collaborate to market biosimilars in Turkey

Zydus Cadila, a global healthcare provider and Eczacibasi Ilac Pazarlama AS, a leading healthcare company of Turkey, have signed a strategic collaboration agreement to market biotech products in the Turkish market. The agreement involves the import ...
 PharmaBiz1 week ago Zydus Cadila and Eczacibasi enter into a strategic collaboration to market biosimilars in Turkey  Equity Bulls1 week ago
India Infoline

ZYDUS GETS FDA APPROVAL FOR PHASE II CLINICAL TRIAL OF LIVER DRUG

Zydus Cadila has secured the approval of the US Food and Drug Administration (FDA) for phase II clinical trial of Saraglitazar in patients with non-alcoholic steatohepatitis (NASH) of the liver in US. The approval is for liver drug Saroglitazar in ...
 Pharmacy Choice2 weeks ago Zydus Cadila receives US FDA approval for phase 2 trials of saroglitazar  PharmaBiz3 weeks ago Zydus Cadila receives USFDA approval to initiate Phase 2 clinical trials of Saroglitazar  Finalaya.com3 weeks ago Zydus Cadila gets FDA nod to begin Phase II trial of saroglitazar to treat NASH in US  Drug Development Technology3 weeks ago
[x]  

Zydus Cadila to present new scientific data on Saroglitazar at annual scientific sessions of ADA

Zydus Cadila announced that new data on Saroglitazar have been selected for presentations at the 76th Annual Scientific Sessions of the American Diabetes Association (ADA) in New Orleans, Louisiana, USA from 10-14 June, 2016. Real-world patient ...
 PharmaBiz2 weeks ago Cadila's new data on Saroglitazar to be presented at ADA  HT Syndication2 weeks ago New Scientific Data of Investigational Lipaglyn[TM] (Saroglitazar), and Real World Data in Patients will be Featured at American Diabetes Association (ADA) 76th Scientific Sessions  Bloomberg2 weeks ago Zydus Cadila to present new data on Saroglitazar at ADA  Equity Bulls2 weeks ago
[x]  

Cadila Q4 net up 11% to Rs 389 cr; to raise up to Rs 18,500 cr

New Delhi, May 13 () Zydus Cadila group firm Cadila Healthcare today reported a 10.93 per cent rise in net profit to Rs 388.7 crore for the March quarter and also received nod from its board to raise up to Rs 18,500 crore through issuance of shares ...
 Times of India1 month ago Zydus Cadila standalone net down marginally at Rs 338 cr in Q4  Business Line1 month ago Cadila profit at Rs 389 cr; to raise up to Rs 18,500 cr  The Freepress Journal1 month ago Cadila Q4 net up 11% to Rs 389 crore; to raise up to Rs 18,500 crore  Economic Times1 month ago
[x]  
Business Standard India

Zydus to start phase-II clinical trial for saroglitazar in US

Ahmedabad-based Zydus Cadila on Saturday announced that USFDA has approved the company's plan to initiate a Phase-II clinical trial of Saroglitazar in patients with Non-Alcoholic Steatohepatitis (NASH) of the liver. This randomised, double-blind ...
 Smart Investor3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus cadila
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less